KPCB XII Associates’s Inspire Medical Systems INSP Stock Holding History

KPCB XII Associates’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-396,406	Closed	-$34.5M	–	2
2020 Q2	$34.5M	Hold	396,406	–	–	96.96%	1
2020 Q1	$23.9M	Hold	396,406	–	–	97.36%	1
2019 Q4	$29.4M	Hold	396,406	–	–	97.41%	1
2019 Q3	$24.2M	Hold	396,406	–	–	47.02%	2
2019 Q2	$24M	Hold	396,406	–	–	57.65%	1
2019 Q1	$22.5M	Sell	396,406 -1,359,900	-77%	-$73.5M	36.12%	2
2018 Q4	$74.2M	Buy	+1,756,306	New	+$74.7M	54.1%	1

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

KPCB XII Associates's INSP Position: Q3 2020 in Review

KPCB XII Associates sold out of Inspire Medical Systems (INSP) in Q3 2020, closing a stake of 396,406 shares — an estimated $34.5M sold.

KPCB XII Associates first reported a position in INSP in Q4 2018 and held it in 7 quarters. The position peaked at $74.2M in Q4 2018. 203 funds tracked by Wall St. Rank hold INSP as of Q3 2020.

KPCB XII Associates reported no remaining Inspire Medical Systems position as of Q3 2020 after selling out during the quarter.
KPCB XII Associates sold 396,406 Inspire Medical Systems shares in Q3 2020, an estimated $34.5M.
KPCB XII Associates first reported a position in Inspire Medical Systems in Q4 2018 and held it in 7 quarters.
KPCB XII Associates's Inspire Medical Systems position peaked at $74.2M in Q4 2018.
203 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2020.

Based on KPCB XII Associates's 13F filing for Q3 2020, filed 20 Oct 2020.